Kidney International (1992) 42, 1178–1183; doi:10.1038/ki.1992.402
Alport syndrome and diffuse leiomyomatosis: Deletions in the 5' end of the COL4A5 collagen gene
Corinne Antignac, Jing Zhou, Marek Sanak, Pierre Cochat, Bernard Roussel, Georges Deschênes, Françoise Gros, Bertrand Knebelmann, Marie-Claude Hors-Cayla, Karl Tryggvason and Marie-Claire Gubler
INSERM U192 and INSERM U12, Hôpital Necker-Enfants Malades, Paris, France; Biocenter and Department of Biochemistry, University of Oulu, Oulu, Finland; and Unité de Néphrologie Pédiatrique, Hôpital Edouard Herriot, Lyon, Clinique de Pédiatrie et de Puériculture, American Memorial Hospital, Reims, and Service de Néphrologie Pédiatrique, Hôpital de Clocheville, Tours, France
Correspondence: Corinne Antignac MD, INSERM U192, Tour Lavoisier, Hôpital Necker Enfants-Malades, 149 rue de Sèvres, 75015 Paris, France.
Received 24 February 1992; Revised 19 June 1992; Accepted 22 June 1992.
Top of pageAbstract
Alport syndrome and diffuse leiomyomatosis: Deletions in the 5' end of the COL4A5 collagen gene. Alport syndrome (AS) is an hereditary glomerulonephritis that is mainly inherited as a dominant X-linked trait. Structural abnormalities in the type IV collagen
5 chain gene (COL4A5), which maps to Xq22, have recently been detected in several patients with AS. The association of AS with diffuse esophageal leiomyomatosis (DL) has been reported in 24 patients, most of them also suffering from congenital cataract. The mode of transmission and the location of the gene(s) involved in this association have not been elucidated. Southern blotting using cDNA probes spanning the whole COL4A5 and a 5' end COL4A5 genomic probe showed that three out of three patients with the DL-AS association had a deletion in the 5' part of the COL4A5 gene extending beyond its 5' end. This indicates that the same gene, COL4A5, is involved in classical AS and in DL-AS and that the transmission of DL-AS is X-linked dominant. These results also suggest that leiomyomatosis might be due to the alteration of a second gene involved in smooth muscle cell proliferation, which is located upstream of the COL4A5 gene, and that there might be a contiguous gene deletion syndrome, involving at least the genes coding for congenital cataract, DL and AS.
Top of pageReferences
- Alport AC: Hereditary familial congenital haemorrhagic nephritis. Brit Med J (Clin Res) 1:504–506, 1927
- Atkin CL, Gregory MC, Border WA: Alport syndrome, in Diseases of the Kidney (4th ed), edited by Schrier RW, Gottschalk CW, Boston, Little Brown, 1988, p 617–641
- Gubler MC, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib: Alport's syndrome: A report of 58 cases and a review of the literature. Am J Med 70:493–505, 1981 | Article | PubMed | ISI | ChemPort |
- Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M: The genetics of classic Alport's syndrome. Lancet 2:1005–1007, 1988 | PubMed | ISI | ChemPort |
- Atkin CL, Hasstedt SJ, Menlove L, Cannon L, Kirschner N, Schwartz C, Nguyen K, Skolnick MH: Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 42:249–255, 1988 | PubMed | ISI | ChemPort |
- Flinter FA, Abbs S, Bobrow M: Localization of the gene for classic Alport syndrome. Genomics 4:335–338, 1989 | Article | PubMed | ChemPort |
- Brunner H, Schröder C, Van Bennekom C, Lambermon E, Tuerlings J, Menzel D, Olbing H, Monnens LEO, Wierenga B, Ropers HH: Localization of the gene for X-linked Alport's syndrome. Kidney Int 34:507–510, 1988 | PubMed | ChemPort |
- Szpiro-Tapia S, Bobrie G, Guilloud-Bataille M, Heuertz S, Julier C, Frezal J, Grünfeld JP, Hors-Cayla MC: Linkage studies in X-linked Alport syndrome. Hum Genet 81:85–87, 1988
- Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen
chain with restriction kidney distribution and assignment of its gene to the locus of X-linked Alport syndrome. Proc Natl Acad Sci USA 87:1606–1610, 1990 | PubMed | ChemPort | - Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 247:1224–1227, 1990
- Zhou J, Barker DF, Hostikka SL, Gregory MC, Atkin CL, Tryggvason K: Single base mutation in
5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9:10–18, 1991 - Boye E, Vetrie D, Flinter F, Buckle B, Pihlajaniemi T, Hamalainen ER, Myers JC, Bobrow M, Harris A: Major rearrangements in the
5(IV) collagen gene in three patients with Alport syndrome. Genomics 11:1125–1132, 1991 - Gregory MC, Skinner B, Atkin CL, Barker DF: A novel mutation in COL4A5 relates three families with type IV Alport syndrome. (abstract) J Am Soc Nephrol 2:254, 1991
- Kashtan CE, Micheaf, Kleppel MM: Alport syndrome. Association of deletions in the COL4A5 gene with post-transplant anti-GBM nephritis. (abstract) J Am Soc Nephrol 2:256, 1991
- Netzer KO, Renders L, Pullig O, Tryggvason K, Weber M: Mutations in the COL4A5 gene in X-linked Alport syndrome. (abstract) J Am Soc Nephrol 2:257, 1991
- Renieri A, Seri M, Myers JC, Pihlajaniemi T, Sessa A, Rizzoni G, De Marchi M: Alport syndrome caused by a 5' deletion within the COL4A5 gene. Hum Genet 89:120–121, 1992
- Renieni A, Seri M, Myers JC, Pihlajaiemi T, Massella L, Rizzoni G, De Marchi M: De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome. Hum Mol Genet 1:127–129, 1992
- Smeets HJM, Melenhorst JJ, Lemmink HH, Schroder CH, Nelen MR, Zhou J, Hostikka SL, Ropers HH, Jansweijer MCE, Monnens LAH, Brunner HG, Van Oost BA: Mutations in the COL4A5 collagen gene leading to different types of Alport syndrome. Kidney Int 42:83–88, 1992
- Zhou J, Hertz JM, Tryggvason K: Mutation in the
5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: Detection by denaturing gradient gel electrophoresis of a PCR product. Am J Hum Genet 50:1291–1300, 1992 | PubMed | ISI | ChemPort | - Zhou J, Hertz JM, Leinonen A, Tryggvason K: Complete amino acid sequence of the human
5(IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. J Biol Chem 267:12475–12481, 1992 | PubMed | ISI | ChemPort | - Antignac C, Deschenes G, Gros F, Knebelmann B, Tryggvason K, Gubler MC: Mutations in the COL4A5 gene in Alport syndrome. (abstract) J Am Soc Nephrol 2:249, 1991
- Gubler MC, Deschenes G, Knebelman B, Hors MC, Noel LH, Grünfeld JP, Broyer M, Tryggvason K, Antignac C: Clinical and immunohistochemical heterogeneity of X-linked Alport syndrome. Research for mutations in the
5(IV) collagen gene. (abstract) Pediatr Nephrol 5:C20, 1991 - Knebelmann B, Deschenes G, Gros F, Hors MC, Grünfeld JP, Tryggvason K, Gubler MC, Antignac C: Substitution of arginine for glycine 325 in the collagen
5(IV) chain associated with X-linked Alport syndrome: Characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet 51:135–142, 1992 | PubMed | ChemPort | - Heald J, Moussalli H, Hasleton PS: Diffuse leiomyomatosis of the oesophagus. Histopathology 10:755–759, 1986
- Bourque MD, Spigland N, Bensoussan AL, Collin PP, Saguem MH, Brochu P, Blanchard H, Reinberg O: Esophageal leiomyoma in children: Two case reports and review of the literature. J Pediatr Surg 85:303–305, 1989
- Marshall JB, Diaz-Arias AA, Bochna GS, Vogele KA: Achalasia due to diffuse esophageal leiomyomatosis and inherited as an autosomal dominant disorder. Report of a family study. Gastroenterology 98:1358–1365, 1990 | PubMed | ISI | ChemPort |
- Rosen RM: Familial multiple upper gastrointestinal leiomyoma. Gastroenterol 85:303–305, 1990
- Garcia Torres R, Guarner V: Leiomiomatosis del esophago, traqueo bronquial y genital asociada con nefropatia hereditaria tipo Alport: Un nuevo síndrome. Rev Gastroenterol Mex 48:163–170, 1983
- Roussel B, Birembaut P, Gaillard D, Puchelle JC, D'Albignac G, Pennaforte F, Fandre M: Léiomyomatose oesophagienne familiale associée à un syndrome d'Alport chez un garçon de 9 ans. Helv Paediat Acta 41:359–368, 1986
- Cochat P, Guibaud P, Garcia Torres R, Roussel B, Guarner V, Larbre F: Diffuse leiomyomatosis in Alport syndrome. J Pediatr 113:339–343, 1988 | PubMed | ChemPort |
- Leborgne J, Le Neel JC, Heloury Y, Audoin AF, David A, Babut JM, Lenne Y: La léiomyomatose oesophagienne diffuse. A propos de 5 observations dont 2 cas familiaux. Chirurgie 115:277–286, 1989
- Leichter HE, Vargas J, Cohen AH, Ament M, Salusky IB: Alport's syndrome and achalasia. Pediatr Nephrol 2:312–314, 1988
- Hasegawa S, Saitoh A, Imai A, Kikuta Y, Matsumoto Y, Ohi R: A case of non-Alport's hereditary nephritis with esophageal leiomyomatosis. (abstract) Paediatr Nephrol 3:C188, 1989
- McCartney PJ, McGuiness R: Alport's syndrome and the eye. Aust NZ J Ophtal 17:165–168, 1989
- Wittig BM, Treichel U, Kohler H, Rumpelt HJ, Meyer ZUM, Buschenfelde KH: Léiomyomatose des Gastrointestinalund Urogenitaltrakts in Kombination mit hereditärer Nephritis. Med Klin 85:122–124, 1990
- Legius E, Proesmans W, Van Damme B, Geboes K, Lerut T, Eggermont E: Muscular hypertrophy of the oesophagus and "Alport-like" glomerular lesions in a boy. Eur J Pediatr 149:623–627, 1990
- Rabushka LS, Fishman EK, Kuhlman JE, Hruban RH: Diffuse esophageal leiomyomatosis in a patient with Alport syndrome: CT demonstration. Radiology 179:176–178, 1991
- Lonsdale RN, Roberts PF, Vaughan R, Thiru S: Familial oesophageal leiomyomatosis and nephropathy. Histopathology 20:127–133, 1992
- Weinberg RA: Tumor suppressor genes. Science 254:1138–1146, 1991 | Article | PubMed | ISI | ChemPort |
- McKusick VA: Cataract, congenital total, with posterior suturai opacities in heterozygotes, in Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive and X-linked Phenotypes, edited by McKusick VA, 9th ed, Baltimore, The John Hopkins University Press, 1990, p. 1569